Status:
UNKNOWN
Canadian Study of Prediction of Risk and Evolution to Dialysis, Death and Interim Cardiovascular Events Over Time
Lead Sponsor:
University of British Columbia
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
19+ years
Brief Summary
This study will follow 2500 prevalent Chronic Kidney Disease (CKD) patients with Glomerular Filtration Rate (GFR) from 15-45 ml/min for 30 months with serial measurements every 6 months and subsequent...
Eligibility Criteria
Inclusion
- Patients currently seen by a nephrologist, or referred for evaluation of CKD
- GFR between 15-45 ml/min
- Adults 19 years (depending on age of consent in province) or older
- At pediatric sites study participants will be eligible to participate at age 15 or older
Exclusion
- Organ transplant recipient
- Life expectancy less than 12 months
- Acute Vasculitis
- Bioimpedance sub-study exclusion criteria:
- Amputation (readings are inaccurate)
- Any battery operated or electronic implanted device (such as pacemaker or implanted defibrillator - potential electrical hazard)
- Pregnant women
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
2602 Patients enrolled
Trial Details
Trial ID
NCT00826319
Start Date
June 1 2008
End Date
December 1 2014
Last Update
November 28 2013
Active Locations (25)
Enter a location and click search to find clinical trials sorted by distance.
1
Foothills Hospital
Calgary, Alberta, Canada
2
University of Alberta
Edmonton, Alberta, Canada
3
Penticton Regional Hospital
Penticton, British Columbia, Canada
4
BC Children's Hospital
Vancouver, British Columbia, Canada